Nordic AML Insights: Research and Ph.D. Contributions

This update highlights recent AML research from the Nordic countries, covering topics such as long-term cancer risks following intensive treatment, predictive value of venetoclax sensitivity testing, and new insights into XPO1 as a therapeutic target. The overview also includes data-driven approaches to prognosis and outcomes in real-world settings.
Explore the latest Nordic findings on emerging directions in AML research!